Clinical Trial Update: An Exploratory Study of RGT Strategy on Optimal NUC-experienced Patients [Phase 4]

View source ↗

Summary

Clinical trial update describing an exploratory Phase 4 study of an RGT strategy in nucleoside analogue–experienced patients with chronic hepatitis B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Snippet

Sponsor: Ruijin Hospital | Conditions: Chronic Hepatitis B | Phase 4 | Status: UNKNOWN